MDRX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
MDRX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
The zones of discrimination for M-Score is as such:
An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.
The historical rank and industry rank for Veradigm's Beneish M-Score or its related term are showing as below:
During the past 13 years, the highest Beneish M-Score of Veradigm was 0.00. The lowest was 0.00. And the median was 0.00.
The historical data trend for Veradigm's Beneish M-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Veradigm Annual Data | |||||||||||||||||||||
Trend | Dec12 | Dec13 | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | |||||||||||
Beneish M-Score | Get a 7-Day Free Trial | -2.62 | -2.12 | -2.63 | -1.16 | -2.24 |
Veradigm Quarterly Data | ||||||||||||||||||||
Dec17 | Mar18 | Jun18 | Sep18 | Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | |
Beneish M-Score | Get a 7-Day Free Trial | -0.07 | -2.24 | -2.94 | -3.22 | -2.81 |
For the Health Information Services subindustry, Veradigm's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, Veradigm's Beneish M-Score distribution charts can be found below:
* The bar in red indicates where Veradigm's Beneish M-Score falls into.
The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.
The M-Score Variables:
The M-score of Veradigm for today is based on a combination of the following eight different indices:
M | = | -4.84 | + | 0.92 * DSRI | + | 0.528 * GMI | + | 0.404 * AQI | + | 0.892 * SGI | + | 0.115 * DEPI |
= | -4.84 | + | 0.92 * 0.2663 | + | 0.528 * 1.0485 | + | 0.404 * 0.8065 | + | 0.892 * 1.8972 | + | 0.115 * 0.5019 | |
- | 0.172 * SGAI | + | 4.679 * TATA | - | 0.327 * LVGI | |||||||
- | 0.172 * 1.0452 | + | 4.679 * -0.094311 | - | 0.327 * 0.6795 | |||||||
= | -2.81 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
This Year (Sep22) TTM: | Last Year (Sep21) TTM: |
Total Receivables was $234 Mil. Revenue was 151.922 + 150.898 + 142.672 + 1083.511 = $1,529 Mil. Gross Profit was 83.436 + 79.482 + 73.481 + 418.589 = $655 Mil. Total Current Assets was $811 Mil. Total Assets was $1,691 Mil. Property, Plant and Equipment(Net PPE) was $26 Mil. Depreciation, Depletion and Amortization(DDA) was $169 Mil. Selling, General, & Admin. Expense(SGA) was $360 Mil. Total Current Liabilities was $253 Mil. Long-Term Debt & Capital Lease Obligation was $213 Mil. Net Income was 14.528 + -64.026 + 22.857 + 87.275 = $61 Mil. Non Operating Income was 1.038 + 1.926 + -0.386 + 56.691 = $59 Mil. Cash Flow from Operations was 28.141 + -1.635 + 69.261 + 65.045 = $161 Mil. |
Total Receivables was $464 Mil. Revenue was 144.668 + 141.206 + 133.652 + 386.414 = $806 Mil. Gross Profit was 69.64 + 68.419 + 62.917 + 161.023 = $362 Mil. Total Current Assets was $805 Mil. Total Assets was $2,484 Mil. Property, Plant and Equipment(Net PPE) was $124 Mil. Depreciation, Depletion and Amortization(DDA) was $95 Mil. Selling, General, & Admin. Expense(SGA) was $181 Mil. Total Current Liabilities was $567 Mil. Long-Term Debt & Capital Lease Obligation was $440 Mil. |
1. DSRI = Days Sales in Receivables Index
Measured as the ratio of Revenue in Total Receivables in year t to year t-1.
A large increase in DSR could be indicative of revenue inflation.
DSRI | = | (Receivables_t / Revenue_t) | / | (Receivables_t-1 / Revenue_t-1) |
= | (234.482 / 1529.003) | / | (464.168 / 805.94) | |
= | 0.153356 | / | 0.575934 | |
= | 0.2663 |
2. GMI = Gross Margin Index
Measured as the ratio of gross margin in year t-1 to gross margin in year t.
Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.
GMI | = | GrossMargin_t-1 | / | GrossMargin_t |
= | (GrossProfit_t-1 / Revenue_t-1) | / | (GrossProfit_t / Revenue_t) | |
= | (361.999 / 805.94) | / | (654.988 / 1529.003) | |
= | 0.449164 | / | 0.428376 | |
= | 1.0485 |
3. AQI = Asset Quality Index
AQI is the ratio of asset quality in year t to year t-1.
Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.
AQI | = | (1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) | / | (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1) |
= | (1 - (810.77 + 26.233) / 1690.659) | / | (1 - (804.961 + 123.964) / 2484.306) | |
= | 0.504925 | / | 0.626083 | |
= | 0.8065 |
4. SGI = Sales Growth Index
Ratio of Revenue in year t to sales in year t-1.
Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.
SGI | = | Sales_t | / | Sales_t-1 |
= | Revenue_t | / | Revenue_t-1 | |
= | 1529.003 | / | 805.94 | |
= | 1.8972 |
5. DEPI = Depreciation Index
Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.
DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.
DEPI | = | (Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) | / | (Depreciation_t / (Depreciaton_t + PPE_t)) |
= | (95.295 / (95.295 + 123.964)) | / | (169.373 / (169.373 + 26.233)) | |
= | 0.434623 | / | 0.865889 | |
= | 0.5019 |
Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.
6. SGAI = Sales, General and Administrative expenses Index
The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.
SGA expenses index > 1 means that the company is becoming less efficient in generate sales.
SGAI | = | (SGA_t / Sales_t) | / | (SGA_t-1 /Sales_t-1) |
= | (359.817 / 1529.003) | / | (181.457 / 805.94) | |
= | 0.235328 | / | 0.22515 | |
= | 1.0452 |
7. LVGI = Leverage Index
The ratio of total debt to Total Assets in year t relative to yeat t-1.
An LVGI > 1 indicates an increase in leverage
LVGI | = | ((LTD_t + CurrentLiabilities_t) / TotalAssets_t) | / | ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1) |
= | ((212.641 + 253.091) / 1690.659) | / | ((440.244 + 566.94) / 2484.306) | |
= | 0.275474 | / | 0.405419 | |
= | 0.6795 |
8. TATA = Total Accruals to Total Assets
Total accruals calculated as the change in working capital accounts other than cash less depreciation.
TATA | = | (IncomefromContinuingOperations_t | - | CashFlowsfromOperations_t) | / | TotalAssets_t |
= | (NetIncome_t - NonOperatingIncome_t | - | CashFlowsfromOperations_t) | / | TotalAssets_t | |
= | (60.634 - 59.269 | - | 160.812) | / | 1690.659 | |
= | -0.094311 |
An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.
Veradigm has a M-score of -2.81 suggests that the company is unlikely to be a manipulator.
Thank you for viewing the detailed overview of Veradigm's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.
Shih Yin Ho | director | 222 MERCHANDISE MART, SUITE 2024, CHICAGO IL 60654 |
Susan Rodriguez | director | C/O ARDELYX, INC., 34175 ARDENWOOD BLVD, SUITE 200, FREMONT CA 94555 |
Richard J. Poulton | officer: CFO | 3646 WESTFIELD LANE, GLENVIEW IL 60026 |
Tejal Vakharia | officer: SVP Gerneral Counsel | 222 MERCHANDISE MART PLZ, SUITE 2024, CHICAGO IL 60654 |
David B Stevens | director | 1 IMATION WAY, OAKDALE MN 55128 |
Leah Jones | officer: Chief Financial Officer | 222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654 |
Paul Black | director | 400 WOOD ROAD, BRAINTREE MA 02184 |
Elizabeth Ann Altman | director | 10070 BARNES CANYON ROAD, SAN DIEGO CA 92121 |
Thomas Langan | officer: President and CCO | 222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654 |
Lisa Hammond | officer: SVP & Chief HR Officer | 305 CHURCH AT NORTH HILLS STREET, RALEIGH NC 27609 |
Greg Garrison | director | 222 MERCHANDISE MART PLAZA, CHICAGO IL 60654 |
Lisa Khorey | officer: Chief Client Delivery Officer | 222 MERCHANDISE MART PLAZA, CHICAGO IL 60654 |
Michael Klayko | director | |
Carol J Zierhoffer | director | 100 NORTH POINT CENTER EAST, SUITE 200, ALPHARETTA GA 30022 |
Brian Farley | officer: SVP Gerneral Counsel & Corpora | 222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654 |
From GuruFocus
By PRNewswire • 01-02-2024
By Business Wire • 01-19-2024
By PRNewswire • 01-22-2024
By PRNewswire • 01-18-2024
By Business Wire • 01-04-2024
By PRNewswire • 01-12-2024
By PRNewswire • 01-19-2024
By PRNewswire • 01-02-2024
By PRNewswire • 01-16-2024
By PRNewswire • 12-29-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.